Abstract:ETHNOPHARMACOLOGICAL RELEVANCE: Morus alba L. (mulberry) is a well-known medicinal species that has been used by herbalist doctors for the treatment of diabetes for a long history, and modern ethnopharmacological studies have demonstrated the ameliorating effects of different mulberry extracts toward diabetes-related symptoms and identified a number of α-glucosidase inhibitors as hypoglycemic ingredients.AIM OF THE STUDY: The present study aims to explore new potent α-glucosidase inhibitors from the root bark of M. alba (known as Sang-Bai-Pi in traditional medicine) based on an in vivo antidiabetic evaluation of its extract fractions and further characterize the preliminary mechanism of the new active constituents.MATERIALS AND METHODS: α-Glucosidase inhibitory assay and diabetic mice model were used to locate and evaluate the active fractions from the extract. Diverse separation techniques (e.g. Sephadex LH-20 column chromatograph (CC) and HPLC) and spectroscopic methods (e.g. MS, NMR and ECD) were employed to isolate and structurally characterize the obtained constituents, respectively. Fluorescence quenching, kinetics and molecular docking experiments were conducted to investigate the enzyme inhibitory mechanism of the active compounds.RESULTS: The 80% ethanol eluate from the macroporous resin CC exerted good antidiabetic effects in the tested mice. Fifty-two flavonoids including 22 new ones were then separated and identified, and most of them showed strong inhibition against α-glucosidase with their structure-activity relationship being also discussed. The four new most active ingredients were further characterized to be mixed type of α-glucosidase inhibitors, and their binding modes with the enzyme were also explored.CONCLUSIONS: Our current work has demonstrated that the root bark of M. alba is an extremely rich source of flavonoids as potent α-glucosidase inhibitors and potential antidiabetic agents, which makes it a promising candidate species to develop new natural remedies for the prevention and treatment of diabetes.

A New Flavanone Glycoside with Anti-proliferation Activity from the Root Bark of Morus Alba

Bioassay-guided screening and isolation of α-glucosidase and tyrosinase inhibitors from leaves of Morus alba

Isoprenylated Flavonoids and 2-Arylbenzofurans from the Root Bark of Morus alba L. and Their Cytotoxic Activity against HGC27 Cancer Cells

Characterization of a New Flavone and Tyrosinase Inhibition Constituents from the Twigs of Morus alba L.

Molecular mechanism of anti-cancerous potential of Morin extracted from mulberry in Hela cells.

Bioactive flavonoids and stilbenes from the leaf of Morus alba var. multicaulis

Three New Compounds from Morus Nigra L.

Phenolic constituents from the root bark of Morus alba L. and their cardioprotective activity in vitro

Morusin shows potent antitumor activity for melanoma through apoptosis induction and proliferation inhibition

Three New Isoflavonoid Glycosides From The Mangrove-Derived Actinomycete Micromonospora Aurantiaca 110b

Four new 2-arylbenzofuran derivatives from leaves of Morus alba L.

In vivo hypoglycemic effects of phenolics from the root bark of Morus alba

New Isoprenylated Flavonoids and Adipogenesis-Promoting Constituents from Morus Notabilis.

α-Glucosidase inhibitors and antioxidants from root bark of Morus alba

MORUSINOL, ISOPRENOID FLAVONE FROM MORUS ROOT BARKS

Synthesis of 8-Pentanyl Favonoids and Evaluation of Their Inhibition Against MDA-MB-231 Cell Proliferation

Arginase inhibitory properties of flavonoid compounds from the leaves of Mulberry (Morus alba, Moraceae)

2-Arylbenzofuran and tyrosinase inhibitory constituents of Morus notabilis.

A New Flavonol Glucoside from Aerial Parts of Manaplant Alhagi (alhagi Pseudoalhagi)

Bioassay-guided discovery and identification of new potent α-glucosidase inhibitors from Morus alba L. and the interaction mechanism

Exploring the therapeutic and anti-tumor properties of morusin: a review of recent advances